Upstream Vector Development Technician at AGC Biologics

Bresso, Lombardy, Italy

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceuticals, CDMOIndustries

Requirements

Degree in Biology/Biotechnology
Experience in laboratory with viral vectors
Good knowledge of English language

Responsibilities

Contribute to the development, optimization, and experimental execution of viral vector production processes on small and large scale
Participate in laboratory management activities, reagent procurement, and instrumentation maintenance
Independently collect and report experimental work in writing
Compile GMP documentation

Skills

Key technologies and capabilities for this role

Viral VectorsLaboratory TechniquesGMP DocumentationProcess DevelopmentScale-UpEnglish

Questions & Answers

Common questions about this position

What compensation does AGC Biologics offer for this role?

AGC Biologics offers a highly competitive compensation package.

Is this position remote or does it require on-site work?

This information is not specified in the job description.

What qualifications are required for the Upstream Vector Development Technician role?

Candidates need a degree in Biology/Biotechnology, laboratory experience with viral vectors, and good knowledge of English.

What is the company culture like at AGC Biologics?

The culture is defined by six core values: Knowledge, Trust, Quality, Ingenuity, Accountability, and Teamwork, and features a friendly, collaborative environment that values personal initiative and professional achievement.

What makes a strong candidate for this technician position?

A strong candidate will have a degree in Biology or Biotechnology, hands-on lab experience with viral vectors, good English skills, and the ability to independently document experimental work and handle GMP documentation.

AGC Biologics

Contract development and manufacturing for biopharmaceuticals

About AGC Biologics

AGC Biologics specializes in the development and manufacturing of therapeutic proteins, plasmid DNA, viral vectors, and genetically engineered cells for the biopharmaceutical industry. The company provides end-to-end solutions, assisting clients from the initial development stages to full-scale production. Their services are particularly focused on fast-tracking projects for orphan drugs and rare diseases, which often require quicker timelines. AGC Biologics operates a network of advanced facilities across the U.S., Europe, and Asia, all adhering to strict quality regulations known as current Good Manufacturing Practices (cGMP). What sets AGC Biologics apart from competitors is its commitment to continuous innovation and its recent expansion to enhance capabilities in cell and gene therapy. The company's goal is to support biopharmaceutical companies in bringing new treatments to market efficiently and effectively.

Bothell, WashingtonHeadquarters

2001Year Founded

$613MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Risks

Restructuring and layoffs in Colorado indicate potential financial instability.

Leadership changes may disrupt ongoing projects and affect client trust.

Significant investment in Japan could strain financial resources and divert focus.

Differentiation

AGC Biologics specializes in therapeutic proteins, plasmid DNA, and viral vectors.

The company offers fast-track project capabilities for orphan drugs and rare diseases.

AGC Biologics operates globally with facilities in the U.S., Europe, and Asia.

Upsides

Increased demand for plasmid DNA boosts AGC's gene therapy and vaccine services.

Partnership with BioConnection enhances biodrug development capabilities, attracting more clients.

Expansion in Yokohama aligns with growing mRNA and cell therapy demand.

Land your dream remote job 3x faster with AI

Try Jobo Free